Loading…
Menten AI develops MAUD 1.0, a generative AI platform that designs peptide macrocycles from scratch for complex drug targets. The platform combines AI with physics-based models and quantum simulations to achieve nM potency, oral bioavailability, and cell permeability.
AI named Menten AI in February 2026.